Robert Ang

CEO at Vor Bio

Robert Ang is a highly experienced biotech executive who currently serves as the Board Chair at Enara Bio, a UK-based biotechnology company focused on developing cancer immunotherapies targeting non-classical HLA antigens.3 4

Professional Background

Robert Ang brings over 20 years of executive leadership, strategy consulting, and investing experience in the biopharmaceutical industry.5 His current primary role is President and CEO of Vor Bio, a position he has held since 2019.1 2

Career Highlights

Vor Bio: As President and CEO since 2019, Ang leads the company's efforts in developing engineered hematopoietic stem cell therapies for cancer treatment.1
Previous Roles: Prior to Vor Bio, Ang held strategic and business development positions at companies including:
- Neon Therapeutics (now BioNTech)
- Bavarian Nordic
- Cadence Pharmaceuticals (now Mallinckrodt)1 2
Venture Capital: Ang has experience in biotech venture capital from his time at Frazier Healthcare Ventures, where he invested in companies like Incline Therapeutics and Alnara Pharmaceuticals.1 2
Consulting: He also has strategy consulting experience from his time at Boston Consulting Group.1 2

Education and Medical Background

Robert Ang holds an MBBS (medical degree) from the University of Western Australia and an MBA with honors from Columbia Business School.1 3 He also has general surgery training, with his clinical practice focusing on soft tissue surgery and solid organ transplants.1 2

Board Positions

In addition to his role at Enara Bio, Ang serves on several other boards and committees:

Member of the Board of Directors and Executive Committee of the Alliance for Regenerative Medicine1 2
Member of the Healthcare and Pharmaceutical Management Advisory Board of Columbia Business School1 2

Robert Ang's LinkedIn username is robert-ang-069746, as mentioned in the query.6